X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33) 33
oncology (29) 29
index medicus (27) 27
hematology (26) 26
middle aged (20) 20
female (18) 18
male (18) 18
aged (17) 17
adult (14) 14
health aspects (11) 11
research (10) 10
aged, 80 and over (9) 9
chronic myeloid leukemia (9) 9
genetic aspects (9) 9
leukemia (9) 9
chronic myeloid-leukemia (8) 8
in situ hybridization, fluorescence (8) 8
mutation (8) 8
adolescent (7) 7
cancer (7) 7
telomerase (7) 7
telomere (7) 7
animals (6) 6
apoptosis (6) 6
development and progression (6) 6
antineoplastic agents - therapeutic use (5) 5
care and treatment (5) 5
cell line, tumor (5) 5
chronic myelogenous leukemia (5) 5
expression (5) 5
gene expression (5) 5
hemic and lymphatic diseases (5) 5
imatinib (5) 5
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (5) 5
original (5) 5
cell proliferation (4) 4
cells (4) 4
dna methylation (4) 4
drug therapy (4) 4
gene expression profiling (4) 4
gene mutations (4) 4
hematopoietic stem-cells (4) 4
mice (4) 4
mutation - genetics (4) 4
physiological aspects (4) 4
prognosis (4) 4
properties (4) 4
reverse transcriptase polymerase chain reaction (4) 4
survival (4) 4
telomerase - genetics (4) 4
telomere - ultrastructure (4) 4
treatment outcome (4) 4
young adult (4) 4
age factors (3) 3
analysis (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
diagnosis (3) 3
drug resistance, neoplasm (3) 3
essential thrombocythemia (3) 3
flow cytometry (3) 3
follow-up (3) 3
follow-up studies (3) 3
fusion proteins, bcr-abl - genetics (3) 3
hematology, oncology and palliative medicine (3) 3
hematopoietic stem cell transplantation (3) 3
imatinib mesylate - therapeutic use (3) 3
kaplan-meier estimate (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - genetics (3) 3
leukemia, myelogenous, chronic, bcr-abl positive - pathology (3) 3
leukemia, myeloid, acute - genetics (3) 3
management (3) 3
methylation (3) 3
oncology, experimental (3) 3
protein kinase inhibitors - therapeutic use (3) 3
risk factors (3) 3
rna, messenger - genetics (3) 3
safety (3) 3
stem-cells (3) 3
telomerase - metabolism (3) 3
telomere - metabolism (3) 3
telomeres (3) 3
therapy (3) 3
transplantation (3) 3
tyrosine kinase inhibitors (3) 3
610 medicine & health (2) 2
aberration (2) 2
activation (2) 2
aging - genetics (2) 2
antimetabolites, antineoplastic - therapeutic use (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents - pharmacology (2) 2
article (2) 2
base sequence (2) 2
bcr-abl (2) 2
benzamides (2) 2
biochemistry & molecular biology (2) 2
blotting, western (2) 2
bone neoplasms - genetics (2) 2
bone-marrow transplantation (2) 2
bosutinib (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Leukemia, ISSN 0887-6924, 01/2016, Volume 30, Issue 1, pp. 57 - 64
The Evaluating Nilotinib Efficacy and Safety in Clinical Trials as First-Line Treatment (ENEST1st) study included 1089 patients with newly diagnosed chronic... 
TYROSINE KINASE INHIBITORS | TRIAL | SURVIVAL | CML-STUDY IV | THERAPY | MANAGEMENT | MELANOMA | ONCOLOGY | IMATINIB | 3-YEAR FOLLOW-UP | MOLECULAR RESPONSE | HEMATOLOGY | Drug metabolism | Genetic aspects | Chronic myeloid leukemia | Genetic transcription | Drug therapy | Health aspects | Original
Journal Article
Leukemia, ISSN 0887-6924, 12/2008, Volume 22, Issue 12, pp. 2176 - 2183
Journal Article
Leukemia, ISSN 0887-6924, 06/2016, Volume 30, Issue 6, pp. 1255 - 1262
Journal Article
Forum, ISSN 0947-0255, 7/2014, Volume 29, Issue 4, pp. 316 - 323
Das Spektrum von molekular zielgerichteten Therapieprinzipien bei malignen hämatologischen Erkrankungen hat sich, ausgehend von Modellerkrankungen wie z. B.... 
Molecular targeted therapy | Hematology | Tyrosinkinase | Gynecology | Leukemia | Oncology | Internal Medicine | Anticancer agents | Krebsmedikamente | Lymphoma | Tyrosine kinase | Medicine & Public Health | Leukämie | Molekular zielgerichtete Therapie | Surgical Oncology | Lymphom
Journal Article
Leukemia, ISSN 0887-6924, 04/2016, Volume 30, Issue 4, pp. 823 - 832
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2018, Volume 29, Issue 3, pp. 578 - 587
Abstract Bosutinib (SKI-606) is an oral, dual Src/Abl tyrosine kinase inhibitor (TKI) approved for treatment of patients with Philadelphia chromosome-positive... 
Chronic myeloid leukemia | Safety | Bosutinib | Tyrosine kinase inhibitors | BCR-ABL1 | CHRONIC MYELOGENOUS LEUKEMIA | DASATINIB AND/OR NILOTINIB | CHRONIC-PHASE | HEALTHY-SUBJECTS | FOLLOW-UP | INTOLERANCE | tyrosine kinase inhibitors | PHARMACOKINETICS | ONCOLOGY | safety | IMATINIB | chronic myeloid leukemia | BELA TRIAL | bosutinib | Reviews
Journal Article
Leukemia, ISSN 0887-6924, 11/2017, Volume 31, Issue 11, pp. 2398 - 2406
Journal Article